ARCHIVES

Control-Arm CML Patients In Phase III Gleevec Study Allowed To Switch.

This article is from The Cancer Letter archive.

Vol. 28 No. 04 | January 25, 2002

Download PDF Visit The Full Archive

Related Articles

Congress Close to Approving Appropriations for FY 1985

September 14, 1984

In Brief: Nobel Prize Awarded To Sharp, Roberts For Gene Splicing; ACS Fills Top Positions

October 22, 1993

Erin Fox: Shortages to Continue for 4-6 Years

October 11, 2013

RFA: Clinical Correlative Studies In Solid Tumors

April 3, 1992

Guest Editorial: Don Berry On Cancer Centers Publishing Comparative Survival Data

March 18, 2011

In Brief: Marks’ Appointment As President, Chief Executive Officer Of Memorial Sloan-Kettering, Official

June 27, 1980